Industry
Drug Manufacturers - Specialty & Generic
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
Loading...
Open
1.89
Mkt cap
27M
Volume
173K
High
1.92
P/E Ratio
-0.97
52-wk high
7.48
Low
1.36
Div yield
N/A
52-wk low
1.36
Portfolio Pulse from Anthony Noto
October 26, 2024 | 6:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 17, 2024 | 12:03 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 12:08 pm
Portfolio Pulse from Benzinga Newsdesk
May 09, 2024 | 12:02 pm
Portfolio Pulse from Benzinga Newsdesk
April 16, 2024 | 12:15 pm
Portfolio Pulse from Benzinga Newsdesk
March 15, 2024 | 12:10 pm
Portfolio Pulse from Benzinga Insights
March 15, 2024 | 9:15 am
Portfolio Pulse from Benzinga Insights
March 14, 2024 | 3:00 pm
Portfolio Pulse from Benzinga Newsdesk
February 21, 2024 | 6:20 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.